Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, CrownBio enables clients to deliver superior clinical candidates and accelerate drug development programs. CrownBio also provides… Read More
The Jackson Laboratory is a leading provider of cancer mouse models and In Vivo oncology services and a National Cancer Institute-designated Cancer Center. Drawing on decades of mouse-based oncology research experience, we provide capabilities around model selection and husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies.
Champions Oncology was founded by renowned specialists in the field of cancer diagnosis, treatment, and research. The Champions Oncology team is comprised of seasoned oncology professionals passionately dedicated to working to accelerate oncology drug development, improve treatment outcomes and extend lives. Our core platform, the Champions TumorGraft™ offers an enhanced xenograft mouse avatar …
MI Bioresearch (MI), a preclinical oncology service provider, offers in vitro services, oncology pharmacology, in vivo imaging, and focal radiation to support research programs. Our team explores the effects of your drugs and biologics using both human and syngeneic models and multi-modality imaging systems. MI provides you with decision-driving data to help advance your drug candidate toward the next cancer researchbreakthrough. One Focus. One Purpose. Oncology Research.
INOVOTION is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery.
Our cutting-edge proprietary technology provides early analysis of your compounds before the classical preclinical stage. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process and significantly reduces its costs. INOVOTION has developed a unique technology dedicated to early in vivo EFFICACY and TOXICITY evaluation of anti-cancer drugs.
VIVOPHARM, a CGI company (NASDAQ:CGIX), is a successful and fast-growing precision contract research organization (CRO) providing integrated preclinical services from bench to bedside worldwide. We use our experience and expertise to assist in the planning of and conducting tailored studies, from discovery stages through to clinical…
Repositive is a technology company with the mission to increase discovery, access and sharing of genomic data for the benefit of patients. In 2017 we initiated a collaboration with leading biopharma organisations and CROs to launch the Cancer Models Platform to act as a market place of translational oncology models and a network for oncology researchers. The platform incorporates PDX, CDX, syngeneic and humanised mouse models, 3D in vitro systems and other popular translational cancer models. Our vision is becoming the largest catalogue of commercially available oncology models.